@the_news_21
Covaxin manufacturer, Bharat Biotech today started trials for the booster dose of the vaccine at AIIMS, Delhi and Patna. It will be conducted in phase two clinical trial participants. The booster dose will be given to the participants after six months when they had received their second dose during the trial. Last month, the Drug Controller General of India had given permission to Bharat Biotech to conduct clinical trials for a third booster dose of Covaxin.
TheNews21 is a leading national English news portal. Operating from the island city of Mumbai, it covers regional and federal current affairs related to politics apart from major foreign affairs issues. The portal also hosts in-depth investigation features, developments in the business sector, and keeps a pulse on the world of sports and entertainment.
Address: 104, SP Telange Industrial Estate, Opposite Vir Rubber Company, Kalyan-Badlapur Road, Chikhloli,Ambernath - West, Dist Thane, Maharashtra, India 421 501
